Literature DB >> 32298766

Lytic cell death in metabolic liver disease.

Jérémie Gautheron1, Gregory J Gores2, Cecília M P Rodrigues3.   

Abstract

Regulated cell death is intrinsically associated with inflammatory liver disease and is pivotal in governing outcomes of metabolic liver disease. Different types of cell death may coexist as metabolic liver disease progresses to inflammation, fibrosis, and ultimately cirrhosis. In addition to apoptosis, lytic forms of hepatocellular death, such as necroptosis, pyroptosis and ferroptosis elicit strong inflammatory responses due to cell membrane permeabilisation and release of cellular components, contributing to the recruitment of immune cells and activation of hepatic stellate cells. The control of liver cell death is of fundamental importance and presents novel opportunities for potential therapeutic intervention. This review summarises the underlying mechanism of distinct lytic cell death modes and their commonalities, discusses their relevance to metabolic liver diseases of different aetiologies, and acknowledges the limitations of current knowledge in the field. We focus on the role of hepatocyte necroptosis, pyroptosis and ferroptosis in non-alcoholic fatty liver disease, alcohol-associated liver disease and other metabolic liver disorders, as well as potential therapeutic implications.
Copyright © 2020 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ASH; Ferroptosis; Gaucher's disease; Hemochromatosis; NAFLD; NASH; Necroptosis; Niemann-Pick disease; Programmed cell death; Pyroptosis

Year:  2020        PMID: 32298766      PMCID: PMC7371520          DOI: 10.1016/j.jhep.2020.04.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  145 in total

1.  Pro-inflammatory programmed cell death.

Authors:  B T Cookson; M A Brennan
Journal:  Trends Microbiol       Date:  2001-03       Impact factor: 17.079

Review 2.  Liver fibrosis in alcoholic liver disease.

Authors:  Ramon Bataller; Bin Gao
Journal:  Semin Liver Dis       Date:  2015-05-14       Impact factor: 6.115

3.  Non-alcoholic fatty liver disease in an area of southern Italy: main clinical, histological, and pathophysiological aspects.

Authors:  C Loguercio; V De Girolamo; I de Sio; C Tuccillo; A Ascione; F Baldi; G Budillon; L Cimino; A Di Carlo; M P Di Marino; F Morisco; F Picciotto; L Terracciano; R Vecchione; V Verde; C Del Vecchio Blanco
Journal:  J Hepatol       Date:  2001-11       Impact factor: 25.083

Review 4.  Necroptosis in development, inflammation and disease.

Authors:  Ricardo Weinlich; Andrew Oberst; Helen M Beere; Douglas R Green
Journal:  Nat Rev Mol Cell Biol       Date:  2016-12-21       Impact factor: 94.444

Review 5.  Pyroptosis: host cell death and inflammation.

Authors:  Tessa Bergsbaken; Susan L Fink; Brad T Cookson
Journal:  Nat Rev Microbiol       Date:  2009-02       Impact factor: 60.633

6.  Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity.

Authors:  Jorge Henao-Mejia; Eran Elinav; Chengcheng Jin; Liming Hao; Wajahat Z Mehal; Till Strowig; Christoph A Thaiss; Andrew L Kau; Stephanie C Eisenbarth; Michael J Jurczak; Joao-Paulo Camporez; Gerald I Shulman; Jeffrey I Gordon; Hal M Hoffman; Richard A Flavell
Journal:  Nature       Date:  2012-02-01       Impact factor: 49.962

7.  Phosphatidylserine externalization, "necroptotic bodies" release, and phagocytosis during necroptosis.

Authors:  Sefi Zargarian; Inbar Shlomovitz; Ziv Erlich; Aria Hourizadeh; Yifat Ofir-Birin; Ben A Croker; Neta Regev-Rudzki; Liat Edry-Botzer; Motti Gerlic
Journal:  PLoS Biol       Date:  2017-06-26       Impact factor: 8.029

8.  Unsolved mysteries: How does lipid peroxidation cause ferroptosis?

Authors:  Huizhong Feng; Brent R Stockwell
Journal:  PLoS Biol       Date:  2018-05-24       Impact factor: 8.029

Review 9.  Pyroptosis versus necroptosis: similarities, differences, and crosstalk.

Authors:  Daniel Frank; James E Vince
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

10.  Regulation of NKT cell-mediated immune responses to tumours and liver inflammation by mitochondrial PGAM5-Drp1 signalling.

Authors:  Young Jun Kang; Bo-Ram Bang; Kyung Ho Han; Lixin Hong; Eun-Jin Shim; Jianhui Ma; Richard A Lerner; Motoyuki Otsuka
Journal:  Nat Commun       Date:  2015-09-18       Impact factor: 14.919

View more
  33 in total

Review 1.  Targeted therapeutics and novel signaling pathways in non-alcohol-associated fatty liver/steatohepatitis (NAFL/NASH).

Authors:  Xiaohan Xu; Kyle L Poulsen; Lijuan Wu; Shan Liu; Tatsunori Miyata; Qiaoling Song; Qingda Wei; Chenyang Zhao; Chunhua Lin; Jinbo Yang
Journal:  Signal Transduct Target Ther       Date:  2022-08-13

Review 2.  Roles of RIPK3 in necroptosis, cell signaling, and disease.

Authors:  Michael J Morgan; You-Sun Kim
Journal:  Exp Mol Med       Date:  2022-10-12       Impact factor: 12.153

Review 3.  Hepatic Stellate Cell-Immune Interactions in NASH.

Authors:  James K Carter; Scott L Friedman
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

4.  Rhubarb free anthraquinones improved mice nonalcoholic fatty liver disease by inhibiting NLRP3 inflammasome.

Authors:  Chao Wu; Yanqin Bian; Bingjie Lu; Dan Wang; Nisma Lena Bahaji Azami; Gang Wei; Feng Ma; Mingyu Sun
Journal:  J Transl Med       Date:  2022-06-28       Impact factor: 8.440

5.  The scaffold-dependent function of RIPK1 in experimental non-alcoholic steatohepatitis.

Authors:  Valeria Pistorio; Juliette Tokgozoglu; Vlad Ratziu; Jérémie Gautheron
Journal:  J Mol Med (Berl)       Date:  2022-06-15       Impact factor: 5.606

Review 6.  The role of bile acids in cholestatic liver injury.

Authors:  Shi-Ying Cai; James L Boyer
Journal:  Ann Transl Med       Date:  2021-04

Review 7.  Ferroptosis in Liver Diseases: An Overview.

Authors:  Martina Maria Capelletti; Hana Manceau; Hervé Puy; Katell Peoc'h
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

Review 8.  Cell Death in Liver Diseases: A Review.

Authors:  Layla Shojaie; Andrea Iorga; Lily Dara
Journal:  Int J Mol Sci       Date:  2020-12-18       Impact factor: 5.923

Review 9.  How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Authors:  Yana Geng; Klaas Nico Faber; Vincent E de Meijer; Hans Blokzijl; Han Moshage
Journal:  Hepatol Int       Date:  2021-02-06       Impact factor: 6.047

Review 10.  Chronic Inflammation in Non-Alcoholic Steatohepatitis: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Carmelo Luci; Manon Bourinet; Pierre S Leclère; Rodolphe Anty; Philippe Gual
Journal:  Front Endocrinol (Lausanne)       Date:  2020-12-14       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.